Atika Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Atika Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-233,000	Closed	-$4.97M	–	119
2024 Q1	$4.97M	Buy	233,000 +102,600	+79%	+$1.23M	0.49%	69
2023 Q4	$1.25M	Buy	+130,400	New	+$634K	0.17%	71

Atika Capital Management's FUSN Position: Q2 2024 in Review

Atika Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 233,000 shares — an estimated $4.97M sold.

Atika Capital Management first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $4.97M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Atika Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Atika Capital Management sold 233,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $4.97M.
Atika Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Atika Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $4.97M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.